These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


107 related items for PubMed ID: 31989682

  • 41. Protein Kinase G Activation Reverses Oxidative Stress and Restores Osteoblast Function and Bone Formation in Male Mice With Type 1 Diabetes.
    Kalyanaraman H, Schwaerzer G, Ramdani G, Castillo F, Scott BT, Dillmann W, Sah RL, Casteel DE, Pilz RB.
    Diabetes; 2018 Apr; 67(4):607-623. PubMed ID: 29301852
    [Abstract] [Full Text] [Related]

  • 42. Effect of nitric oxide-cGMP-dependent protein kinase activation on advanced glycation end-product-induced proliferation in renal fibroblasts.
    Huang JS, Chuang LY, Guh JY, Chen CJ, Yang YL, Chiang TA, Hung MY, Liao TN.
    J Am Soc Nephrol; 2005 Aug; 16(8):2318-29. PubMed ID: 15958724
    [Abstract] [Full Text] [Related]

  • 43. Involvement of the nitric oxide-cyclic GMP pathway and neuronal nitric oxide synthase in ATP-induced Ca2+ signalling in cochlear inner hair cells.
    Shen J, Harada N, Nakazawa H, Yamashita T.
    Eur J Neurosci; 2005 Jun; 21(11):2912-22. PubMed ID: 15978003
    [Abstract] [Full Text] [Related]

  • 44. Nitric oxide-cGMP-protein kinase G signaling pathway induces anoxic preconditioning through activation of ATP-sensitive K+ channels in rat hearts.
    Cuong DV, Kim N, Youm JB, Joo H, Warda M, Lee JW, Park WS, Kim T, Kang S, Kim H, Han J.
    Am J Physiol Heart Circ Physiol; 2006 May; 290(5):H1808-17. PubMed ID: 16339835
    [Abstract] [Full Text] [Related]

  • 45. Nitric oxide synthetic pathway and cGMP levels are altered in red blood cells from end-stage renal disease patients.
    Di Pietro N, Giardinelli A, Sirolli V, Riganti C, Di Tomo P, Gazzano E, Di Silvestre S, Panknin C, Cortese-Krott MM, Csonka C, Kelm M, Ferdinandy P, Bonomini M, Pandolfi A.
    Mol Cell Biochem; 2016 Jun; 417(1-2):155-67. PubMed ID: 27206740
    [Abstract] [Full Text] [Related]

  • 46. Human endothelial nitric oxide synthase gene delivery protects against cardiac remodeling and reduces oxidative stress after myocardial infarction.
    Smith RS, Agata J, Xia CF, Chao L, Chao J.
    Life Sci; 2005 Apr 08; 76(21):2457-71. PubMed ID: 15763077
    [Abstract] [Full Text] [Related]

  • 47. Preconditioning-mediated neuroprotection: role of nitric oxide, cGMP, and new protein expression.
    Andoh T, Chock PB, Chiueh CC.
    Ann N Y Acad Sci; 2002 May 08; 962():1-7. PubMed ID: 12076958
    [Abstract] [Full Text] [Related]

  • 48. Decreased synthesis and vasodilation to nitric oxide in piglets with hypoxia-induced pulmonary hypertension.
    Berkenbosch JW, Baribeau J, Perreault T.
    Am J Physiol Lung Cell Mol Physiol; 2000 Feb 08; 278(2):L276-83. PubMed ID: 10666111
    [Abstract] [Full Text] [Related]

  • 49. Sesamin induces nitric oxide and decreases endothelin-1 production in HUVECs: possible implications for its antihypertensive effect.
    Lee CC, Chen PR, Lin S, Tsai SC, Wang BW, Chen WW, Tsai CE, Shyu KG.
    J Hypertens; 2004 Dec 08; 22(12):2329-38. PubMed ID: 15614027
    [Abstract] [Full Text] [Related]

  • 50.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 51. Nitric oxide affects IL-6 expression in human peripheral blood mononuclear cells involving cGMP-dependent modulation of NF-κB activity.
    Siednienko J, Nowak J, Moynagh PN, Gorczyca WA.
    Cytokine; 2011 Jun 08; 54(3):282-8. PubMed ID: 21414799
    [Abstract] [Full Text] [Related]

  • 52. Single L-type Ca(2+) channel regulation by cGMP-dependent protein kinase type I in adult cardiomyocytes from PKG I transgenic mice.
    Schröder F, Klein G, Fiedler B, Bastein M, Schnasse N, Hillmer A, Ames S, Gambaryan S, Drexler H, Walter U, Lohmann SM, Wollert KC.
    Cardiovasc Res; 2003 Nov 01; 60(2):268-77. PubMed ID: 14613856
    [Abstract] [Full Text] [Related]

  • 53. Nitric oxide-mediated regulation of connexin43 expression and gap junctional intercellular communication in mesangial cells.
    Yao J, Hiramatsu N, Zhu Y, Morioka T, Takeda M, Oite T, Kitamura M.
    J Am Soc Nephrol; 2005 Jan 01; 16(1):58-67. PubMed ID: 15537869
    [Abstract] [Full Text] [Related]

  • 54.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 55. Vasodilator-stimulated phosphoprotein serine 239 phosphorylation as a sensitive monitor of defective nitric oxide/cGMP signaling and endothelial dysfunction.
    Oelze M, Mollnau H, Hoffmann N, Warnholtz A, Bodenschatz M, Smolenski A, Walter U, Skatchkov M, Meinertz T, Münzel T.
    Circ Res; 2000 Nov 24; 87(11):999-1005. PubMed ID: 11090544
    [Abstract] [Full Text] [Related]

  • 56.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 57. Enhanced nitric oxide-mediated chemoreceptor inhibition and altered cyclic GMP signaling in rat carotid body following chronic hypoxia.
    He L, Chen J, Liu X, Dinger B, Fidone S.
    Am J Physiol Lung Cell Mol Physiol; 2007 Dec 24; 293(6):L1463-8. PubMed ID: 17921345
    [Abstract] [Full Text] [Related]

  • 58.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 59. eNOS, nNOS, cGMP and protein kinase G mediate the inhibitory effect of pancreastatin, a chromogranin A-derived peptide, on growth and proliferation of hepatoma cells.
    Díaz-Troya S, Najib S, Sánchez-Margalet V.
    Regul Pept; 2005 Feb 15; 125(1-3):41-6. PubMed ID: 15582712
    [Abstract] [Full Text] [Related]

  • 60. Hemoglobin induced NO/cGMP suppression Deteriorate Microcirculation via Pericyte Phenotype Transformation after Subarachnoid Hemorrhage in Rats.
    Li Q, Chen Y, Li B, Luo C, Zuo S, Liu X, Zhang JH, Ruan H, Feng H.
    Sci Rep; 2016 Feb 25; 6():22070. PubMed ID: 26911739
    [Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 6.